| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HNR Acquisition (AMEX:HNRA) reported quarterly losses of $(0.12) per share. The company reported $5.06 million in sales this q...
HNR Acquisition Corp (NYSE:HNRA) (the "Company" or "HNRA") is an independent upstream energy company with oil a...
HNR Acquisition Corp (NYSE:HNRA) (the "Company" or "HNRA") is an independent upstream energy company with oil a...
EF Hutton analyst Tim Moore initiates coverage on HNR Acquisition (AMEX:HNRA) with a Buy rating and announces Price Target o...
- SEC Filing
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announc...